Try For Free 7-Day Free Trial
LLM Capital Partners LLC is a private equity firm that makes growth capital investments in mid-sized companies. The Firm's investment strategy is to provide $10 to $30 million of non-control growth funding to businesses with enterprise values between $15 and $250 million. Broad sectors of interest include healthcare services, business services and niche manufacturing. LLM Capital was formed in 1991 and has offices in Boston, Massachusetts and San Francisco, California.
|Overall||6 of 12|
|Sector (Healthcare Services)||2 of 2|
|Type (Consolidation)||1 of 2|
|State (Tennessee)||2 of 2|
|Country (United States)||6 of 12|
|Year (1999)||5 of 5|
Spectrum Clubs, Inc.
El Segundo, California, United States
Spectrum Clubs, Inc. operates 23 upscale athletic clubs with 12 locations in the Los Angeles, CA market and 11 locations in San Antonio, TX.
American Cellular corp.
Franklin, Tennessee, United States
American Cellular was one of the largest independent rural cellular telephone system operators in the U.S. The Company owned and operated non-wireline FCC-licensed cellular telephone systems primarily in rural areas of the Midwestern and Eastern portions of the U.S. American Cellular was acquired by a joint venture between AT&T and Dobson.
Pharos Capital Group is a private equity firm that provides later-stage equity funding to companies at or near cash-flow break even. Investment funds are typically used to support growth, acquisitions, management buyouts, or recapitalization. Pharos looks to commit $20 to $50 million per transaction. Target sectors include healthcare, business services, and technology. Pharos prefers US-based opportunities. Pharos Capital Group was formed in 1998 and is based in Dallas, Texas.
|Overall||3 of 35|
|Sector (Healthcare Services)||2 of 14|
|Type (Consolidation)||1 of 1|
|State (Tennessee)||2 of 7|
|Country (United States)||3 of 34|
|Year (1999)||2 of 2|
Burlington, Massachusetts, United States
StreamServe, Inc. is a provider of enterprise content management solutions for banking, supply chain, insurance, and utilities industries.
Nashville, Tennessee, United States
SmartDM, a full-service direct marketing agency based in Nashville, Tenn., that offers comprehensive direct marketing services and information management for mid-sized companies. It that has 90 employees in the company's main office in Nashville and in Kansas City, Las Vegas and New York. SmartDM has more than 100 clients, including Wyndham Hotels Worldwide, Gaylord Entertainment, Harrah's Entertainment, the American Red Cross, Comcast-Spectacor, several leading consumer finance and mortgage companies, the National Basketball Association, Bass Pro Shops and many other sports-related enterprises.
JLL Partners, Inc. is a private equity investment firm that invests alongside management in middle-market companies. JLL prefers control investments in sectors such as healthcare services, medical products, food and consumer products, chemicals, broadcasting, transportation, automotive, industrial manufacturing, and distribution. In addition to traditional buyout transaction, JLL also seeks distressed/turnaround situations. JLL Partners was formed in 1988 and is based in New York City.
|Overall||2 of 39|
|Sector (Healthcare Services)||1 of 4|
|Type (Consolidation)||1 of 2|
|State (Tennessee)||1 of 2|
|Country (United States)||2 of 37|
|Year (1999)||1 of 1|
Freedom Chemical Co.
Huntington Beach, California, United States
Freedom Chemical Co. was a leading global manufacturer of specialty and fine chemicals for sale to a variety of customers who used these chemicals to enhance the performance of their finished products.
PCS Health Systems Inc.
Scottsdale, Arizona, United States
PCS Health Systems, Inc. is a pharmacy benefit manager, providing drug and health management solutions for health plans and patients. As America's premier pharmaceutical care system, PCS works to encourage proper drug use and helps to lower the cost of drugs for its clients. PCS manages and monitors approximately 300 million individual prescriptions each year representing $10 billion in drug expenditures.